Papadimitriou Christos

Papadimitriou Christos holds the Donovan Family Professorship of Computer Science at Columbia University. His work intersects computational science with oncology, focusing on molecular diagnostics, targeted therapies, and clinical trial design in cancer research. He has contributed to advancements in genetic testing methodologies, biomarker discovery for immunotherapy, and precision medicine strategies for solid tumors.

Research interests include the molecular mechanisms of cancer progression, genomic instability in tumors, and translational applications of bioinformatics in oncology. Key areas of study involve next-generation sequencing (NGS) for homologous recombination deficiency (HRD) detection, PD-L1 expression profiling in circulating tumor cells, and combination therapies involving PARP inhibitors and immune checkpoint blockers.

Notable contributions include leadership in phase III clinical trials such as DUO-E (durvalumab + olaparib for endometrial cancer) and ENGOT-EN11 (pembrolizumab in adjuvant endometrial cancer settings). His work emphasizes improving outcomes through integrative approaches combining computational analysis with clinical oncology practice.

Publications span over two decades, with recent focus on biomarker validation (e.g., RediScore pipeline), therapeutic response prediction models, and molecular profiling of pancreatic/ovarian cancers. Active collaborations involve multidisciplinary teams in gynecologic oncology, gastrointestinal malignancies, and hereditary cancer predisposition syndromes.